Navigation Links
Drug Trial Victims Could Develop Cancer

The victims of a drugs trial which went wrong could now develop serious illnesses like cancer according to the solicitor representing them.//

The six volunteers of the trials at Northwick Park Hospital in north-west London were left seriously ill earlier this year.

Martyn Day, a solicitor for several of these men said that they were left to face "the most terrible future".

Parexel, a clinical research organization, which arranged the trials, on behalf of TeGenero, a German pharmaceutical company claims that all guidelines were followed.

One of the victims, Nav Modi, found out that his immune system was unlikely to be able to fight off serious illnesses, from independent tests carried out on him and three other victims, arranged by Mr Day.

He said, "I don't know what's going to happen the next day. Every time I go to bed I feel that I won't be able to see the sun tomorrow."

Following the drug TGN1412 trial Mr Modi suffered multiple organ failure and is now seeking compensation.

Mr Day, said: "The reality is that they're going to have to face the most terrible future prospect of the most serious cancers happening at any time, the prospect of serious diseases, the most terrible, terrible time."

The Medicines and Healthcare products Regulatory Authority (MHRA) had previously stated that Parexel failed to follow proper procedures. In addition it was found that there was no contract in place between TeGenero and Parexel at the beginning of the trial.

TeGenero has continuously claimed that the men's reactions were "completely unexpected" and did not reflect the results obtained from the earlier laboratory studies.


'"/>




Page: 1

Related medicine news :

1. Results Of Human Trials Of Hungarian Bird-Flu Vaccine Expected Today
2. Vaccine For Dengue Fever On Trial In Asia-Pacific
3. DNA Vaccine Trials Against HIV Virus In Sweden Nurture Hope
4. Clinical Trials of New Drug Febuxostat Show Promise in Gout Treatment
5. Sex, Race Influence Lung Cancer Trial Participation
6. Clinical Trials Of New Anti-Cancer Drug To Be Initiated In New Zealand
7. Diarrhea Vaccine Trials Promises Prevention of Rotavirus Infection
8. New Generation Clinical Trials Could Save Time And Money, Improve Patient Care
9. China Begins Human Trials For HIV/AIDS Drug
10. Patients Should Be Entitled to "Humane Compensation" if Drug Trials Go Wrong
11. HIV/AIDS Vaccine Trial To Be Initiated Soon
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in ... 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced ... 2017. , The annual award competition recognizes editorial and design excellence across a range ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... On ... holding a treadmill relay – Miles by Moonlight to raise money for the American ... $300 or more. , Teams will work together to keep their treadmills moving ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... first interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), ... patient education, today announce a new strategic alliance. , As CPEN’s strategic ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief ... advancements to physician colleagues, skilled nursing facility medical directors and other clinicians at ... of Wound Care." , "At many of these conferences we get to educate ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, the ... by Walgreens and pharmacy benefit manager Prime Therapeutics LLC ... brand, which included the unveiling of new signage at ... as well as at a few other company-owned facilities ... brand to patients, some of whom will begin to ...
(Date:9/28/2017)... Sept. 28, 2017 Cohen Veterans Bioscience and ... use of wearable and home sensors for real-time monitoring ... Signal Foundation, a nonprofit organization focused on disruptive health ... an affordable analytical system to record and integrate behavioral, ... ...
(Date:9/25/2017)...  EpiVax, Inc., a leader in the fields ... announced the launch of EpiVax Oncology Inc., a ... cancer vaccines. EpiVax has provided $500,000 in seed ... technologies to the new precision immunotherapy venture. Gad ... as Chief Executive Officer. Gad brings over 25 ...
Breaking Medicine Technology: